tiprankstipranks
Pharmacyte Biotech, Inc. (PMCB)
:PMCB
US Market

PharmaCyte Biotech (PMCB) Income Statement

Compare
225 Followers

PharmaCyte Biotech Income Statement

Last quarter (Q2 2025), PharmaCyte Biotech's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, PharmaCyte Biotech's net income was $-1.47M. See PharmaCyte Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 8.52M$ 6.46M$ 4.39M$ 3.62M$ 3.83M
Depreciation and Amortization
$ 0.00$ 6.46M$ 4.39M$ 3.62M$ 3.83M
EBITDA
$ 0.00$ 0.00$ 0.00$ 0.00$ -3.83M
Operating Income
$ -6.52M$ -6.46M$ -4.39M$ -3.62M$ -3.83M
Other Income/Expenses
$ 6.85M$ 2.14M$ 152.85K$ 71.75K$ -493.00
Pretax Income
$ 333.76K$ -4.32M$ -4.24M$ -3.55M$ -3.83M
Net Income
$ 333.76K$ -4.32M$ -4.09M$ -3.55M$ -3.83M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.80$ -0.22$ -0.26$ -2.46$ -4.23
Diluted EPS
$ -1.80$ -0.22$ -0.26$ -2.46$ -4.23
Weighted Average Shares Outstanding
9.58M 19.49M 15.52M 1.45M 903.81K
Weighted Average Shares Outstanding (Diluted)
9.58M 19.49M 15.52M 1.45M 903.81K
Currency in USD

PharmaCyte Biotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis